Alphadyne Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Alphadyne Asset Management's VRTX Position: Q3 2026 in Review
Alphadyne Asset Management sold out of Vertex Pharmaceuticals (VRTX) in Q3 2026, closing a stake of 73 shares — an estimated $37.4K sold.
Alphadyne Asset Management first reported a position in VRTX in Q1 2026 and held it in 2 quarters. The position peaked at $3.98M in Q1 2026. 1,793 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.
- Alphadyne Asset Management reported no remaining Vertex Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- Alphadyne Asset Management sold 73 Vertex Pharmaceuticals shares in Q3 2026, an estimated $37.4K.
- Alphadyne Asset Management first reported a position in Vertex Pharmaceuticals in Q1 2026 and held it in 2 quarters.
- Alphadyne Asset Management's Vertex Pharmaceuticals position peaked at $3.98M in Q1 2026.
- 1,793 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.
Based on Alphadyne Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.